Anti-SLAMF7/CS1 Antibody (Elotuzumab)
Catalog No.
F1482
Anti-SLAMF7/CS1 Antibody (Elotuzumab)
Featured Products
Elotuzumab is aSLAMF7 Elotuzumab is a monoclonal antibody that targets a receptor for leukemia. When given as a single active molecule in relapsed or refractory multiple myeloma (RRMM), elotuzumab has no significant anti-myeloma activity. Elotuzumab may improve responses and outcomes when used in combination with other anti-myeloma active molecules.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
915296-00-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Empliciti, HuLuc63, PDL063
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9NQ25
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
SLAMF7 / CS1
Please avoid freeze-thaw cycles.